| Index | — | P/E | 7.34 | EPS (ttm) | 25.28 | Insider Own | — | Shs Outstand | 6.85M | Perf Week | -11.20% |
| Market Cap | 1.27B | Forward P/E | 6.79 | EPS next Y | 27.32 | Insider Trans | -0.00% | Shs Float | 3.39M | Perf Month | -14.27% |
| Enterprise Value | 1.40B | PEG | 1.19 | EPS next Q | 5.54 | Short Float | 36.54% | Perf Quarter | 17.62% | ||
| Income | 180.00M | P/S | 1.50 | EPS this Y | 94.50% | Short Ratio | 7.96 | Perf Half Y | 26.11% | ||
| Sales | 847.00M | P/B | 2.51 | EPS next Y | -0.18% | ROA | 18.65% | Short Interest | 1.24M | Perf YTD | 12.74% |
| Book/sh | 74.04 | P/C | 6.20 | EPS next 5Y | 6.16% | ROE | 51.88% | 52W High | 226.16 -17.93% | Perf Year | 49.08% |
| Cash/sh | 29.94 | P/FCF | 4.64 | EPS past 3/5Y | — -15.75% | ROIC | 33.39% | 52W Low | 83.99 120.98% | Perf 3Y | 556.29% |
| Dividend Est. | — | EV/EBITDA | 3.66 | Sales past 3/5Y | 58.68% 26.14% | Gross Margin | 51.26% | Volatility | 6.37% 5.67% | Perf 5Y | — |
| Dividend TTM | — | EV/Sales | 1.66 | EPS Y/Y TTM | 168.94% | Oper. Margin | 43.02% | ATR (14) | 12.00 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 4.96 | Sales Y/Y TTM | 6.81% | Profit Margin | 21.25% | RSI (14) | 38.11 | Recom | 2.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 5.00 | EPS Q/Q | — | SMA20 | -8.71% | Beta | 1.74 | Target Price | 310.00 |
| Payout | 28.91% | Debt/Eq | 0.67 | Sales Q/Q | -13.52% | SMA50 | -8.68% | Rel Volume | 1.64 | Prev Close | 200.15 |
| Employees | 1,037 | LT Debt/Eq | 0.65 | Earnings | Nov 05 | SMA200 | 23.28% | Avg Volume | 157.39K | Price | 185.60 |
| IPO Date | Apr 04, 2022 | Option/Short | No / Yes | EPS/Sales Surpr. | 89.34% -1.99% | Net Debt/EBITDA | 0.35 | Volume | 257,798 | Change | -7.27% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-11-26 | Reiterated | Lake Street | Buy | $235 → $310 |
| Jun-02-26 | Initiated | Lake Street | Buy | $235 |
| Aug-26-25 | Reiterated | Maxim Group | Buy | $45 → $205 |
| Sep-18-24 | Reiterated | Maxim Group | $45 |
Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 847 | 875 | 480 | 248 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 413 | 431 | 284 | 213 | — | — | — | — | — | |
| Gross Profit | 434 | 444 | 196 | 35 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 63 | 169 | 59 | 36 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 7 | 0 | 7 | 31 | — | — | — | — | — | |
| Operating Income | 364 | 276 | 131 | -32 | — | — | — | — | — | |
| Interest Expense | 20 | 22 | 20 | 16 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -1 | -9 | -1 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | 344 | 245 | 110 | -48 | — | — | — | — | — | |
| Income Taxes | 71 | 64 | 14 | -5 | — | — | — | — | — | |
| Consolidated Net Income | 180 | 71 | 52 | -46 | — | — | — | — | — | |
| Net Income From Continuing Operations | 273 | 180 | 95 | -43 | — | — | — | — | — | |
| Net Income | 180 | 71 | 52 | -46 | — | — | — | — | — | |
| EPS (Recurring) | 26.23 | 11.13 | 10.23 | -10.39 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 26.23 | 11.13 | 10.23 | -10.39 | — | — | — | — | — | |
| EPS (Diluted) | 25.28 | 10.48 | 9.71 | -10.39 | — | — | — | — | — | |
| EBITDA | 384 | 288 | 149 | -15 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 7.34 | 15.71 | 3.26 | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.53 | 1.13 | 0.33 | 0.44 | — | — | — | — | — | |
| Gross Margin | 51.24 | 50.74 | 40.83 | 14.11 | — | — | — | — | — | |
| Operating Margin | 42.98 | 31.54 | 27.29 | -12.90 | — | — | — | — | — | |
| Net Margin | 21.25 | 8.11 | 10.83 | -18.55 | — | — | — | — | — | |
| Shares Outstanding | 7 | 6 | 5 | 4 | — | — | — | — | — | |
| Market Capitalization | 1,299 | 988 | 158 | 108 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Saunders Scott J | Director | Sep 18 '26 | Sale | 214.25 | 203 | 43,493 | 400 | Sep 18 |
| Reed Michael Lee | Director | Jul 31 '26 | Option Exercise | 0.00 | 603 | 0 | 670 | Aug 03 |
| Saunders Scott J | Director | Jul 31 '26 | Option Exercise | 0.00 | 603 | 0 | 603 | Aug 03 |
| Jaumot Frank E | Director | Jul 31 '26 | Option Exercise | 0.00 | 603 | 0 | 753 | Aug 03 |
| Grenas Cheryl Yvonne | Director | Jul 31 '26 | Option Exercise | 0.00 | 603 | 0 | 670 | Aug 03 |
| Vo Thomas T. | Chief Executive Officer | Mar 10 '26 | Option Exercise | 0.00 | 18,016 | 0 | 1,846,213 | Apr 10 |
| Bamburg Wesley Shane | Chief Operating Officer | Mar 11 '26 | Option Exercise | 0.00 | 2,411 | 0 | 2,411 | Mar 24 |
| Jaumot Frank E | Director | Mar 20 '26 | Buy | 93.56 | 150 | 14,033 | 150 | Mar 23 |
| Hosseinion Warren | President | Mar 19 '26 | Buy | 94.07 | 252 | 23,706 | 7,765 | Mar 23 |
| Hosseinion Warren | President | Mar 10 '26 | Option Exercise | 0.00 | 13,605 | 0 | 15,739 | Mar 23 |
| Spears Kelvin | Director | Mar 17 '26 | Buy | 94.46 | 10 | 945 | 32,137 | Mar 18 |
| Spears Kelvin | Director | Mar 10 '26 | Option Exercise | 0.00 | 415 | 0 | 32,209 | Mar 18 |
| Montgomery Pamela W. | Chief Legal Officer-Healthcare | Mar 13 '26 | Buy | 88.87 | 79 | 7,021 | 2,758 | Mar 16 |
| Montgomery Pamela W. | Chief Legal Officer-Healthcare | Mar 10 '26 | Option Exercise | 0.00 | 5,132 | 0 | 5,217 | Mar 16 |
| Bates Jon Christian | Chief Financial Officer | Mar 11 '26 | Option Exercise | 0.00 | 1,694 | 0 | 5,527 | Mar 11 |